{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:11:22Z","timestamp":1786979482192,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anaesth"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1007\/bf03013339","type":"journal-article","created":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T22:07:55Z","timestamp":1241215675000},"page":"1167-1173","source":"Crossref","is-referenced-by-count":25,"title":["Prophylactic oral dolasetron mesylate reduces nausea and vomiting after abdominal hysterectomy"],"prefix":"10.1007","volume":"44","author":[{"given":"C. B.","family":"Warriner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Belo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Finegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Canadian Dolasetron Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03013339_CR1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2044.1994.tb14190.x","volume":"49","author":"AR Williams","year":"1994","unstructured":"Williams AR, Hind M, Sweeney BP, Fisher R. The incidence and severity of postoperative nausea and vomiting in patients exposed to positive intra-operative suggestions. Anaesthesia 1994; 49: 340\u20132.","journal-title":"Anaesthesia"},{"key":"BF03013339_CR2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/BF03009605","volume":"40","author":"JHJH Helmers","year":"1993","unstructured":"Helmers JHJH, Briggs L, Abrahamsson J, et al. A singleiv dose of ondansetron 8 mg prior to induction of anaesthesia reduces postoperative nausea and vomiting in gynaecological patients. Can J Anaesth 1993; 40: 1155\u201361.","journal-title":"Can J Anaesth"},{"key":"BF03013339_CR3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/bja\/68.5.466","volume":"68","author":"GNC Kenny","year":"1992","unstructured":"Kenny GNC, Oates JDL, Leeser J, et al. Efficacy of orally administered ondansetron in the prevention of postoperative nausea and vomiting: a dose ranging study. Br J Anaesth 1992; 68: 466\u201370.","journal-title":"Br J Anaesth"},{"key":"BF03013339_CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1213\/00000539-199210000-00017","volume":"75","author":"E Alon","year":"1992","unstructured":"Alon E, Himinelseher S. Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide. Anesth Analg 1992; 75: 561\u20135.","journal-title":"Anesth Analg"},{"key":"BF03013339_CR5","first-page":"S225","volume":"74","author":"FK Orkin","year":"1992","unstructured":"Orkin FK. What do patients want? \u2014 preferences for iminediate postoperative recovery. Anesth Analg 1992; 74: S225.","journal-title":"Anesth Analg"},{"key":"BF03013339_CR6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03010699","volume":"42","author":"J Lerman","year":"1995","unstructured":"Lerman J. Are antiemetics cost-effective for children? (Editorial). Can J Anaesth 1995; 42: 263\u20136.","journal-title":"Can J Anaesth"},{"key":"BF03013339_CR7","first-page":"903","volume":"80","author":"NV Carroll","year":"1995","unstructured":"Carroll NV, Miederhoff P, Cox FM, Hirsch JD. Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg 1995; 80: 903\u20139.","journal-title":"Anesth Analg"},{"key":"BF03013339_CR8","first-page":"243","volume":"73","author":"PA Kapur","year":"1991","unstructured":"Kapur PA. The big \u201clittle problem.\u201d (Editorial) Anesth Analg 1991; 73: 243\u20135.","journal-title":"(Editorial) Anesth Analg"},{"key":"BF03013339_CR9","first-page":"16","volume":"3","author":"B Chevallier","year":"1995","unstructured":"Chevallier B, Cappelaere P, Splinter T, et al. IV dolasetron (DM)vs IV metoclopramide (M) in emesis prevention after cisplatin chemotherapy (CT). (Abstract) Supportive Care in Cancer 1995; 3: 16.","journal-title":"(Abstract) Supportive Care in Cancer"},{"key":"BF03013339_CR10","first-page":"19","volume":"3","author":"Favero A Del","year":"1995","unstructured":"Del Favero A, Bergemt J, Chemaissani A, et al. Single oral doses of dolasetron versus multiple doses of ondansetron in preventing emesis after moderately emetogenic chemotherapy. (Abstract) Supportive Care in Cancer 1995; 3: 19.","journal-title":"(Abstract) Supportive Care in Cancer"},{"key":"BF03013339_CR11","first-page":"21","volume":"3","author":"B Audhuy","year":"1995","unstructured":"Audhuy B, Cappelaere P, Claverie N, et al. Double-blind comparison of the antiemetic efficacy of two single TV doses of dolasetron and one IV dose of granisetron after cisplatin (\u2265 80 mg\/m2) chemotherapy. (Abstract) Supportive Care in Cancer 1995; 3: 21.","journal-title":"(Abstract) Supportive Care in Cancer"},{"key":"BF03013339_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00343919","volume":"3","author":"JM Leclerc","year":"1995","unstructured":"Leclerc JM, Greenberg M, Lau R, et al. Open label IV dolasetron mesylate in pediatric patients receiving moderately to highly emetogenic chemotherapy: pharmacokinetics, efficacy and safety. (Abstract) Supportive Care in Cancer 1995; 3: 37.","journal-title":"(Abstract) Supportive Care in Cancer"},{"key":"BF03013339_CR13","first-page":"36","volume":"3","author":"P Bey","year":"1995","unstructured":"Bey P, Wilkinson PM, Claverie N, et al. IV dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting. (Abstract) Supportive Care in Cancer 1995; 3: 36.","journal-title":"(Abstract) Supportive Care in Cancer"},{"key":"BF03013339_CR14","first-page":"51","volume":"3","author":"AA Fauser","year":"1995","unstructured":"Fauser AA. Pilot study of the antiemetic efficacy of dolasetron in leukemia patients receiving total body irradiation (TBI) and chemotherapy before bonemarrow transplantation. (Abstract) Supportive Care in Cancer 1995; 3: 51.","journal-title":"(Abstract) Supportive Care in Cancer"},{"key":"BF03013339_CR15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/j.1552-4604.1995.tb04111.x","volume":"35","author":"TL Hunt","year":"1995","unstructured":"Hunt TL, Cramer M, Shah A, Stewart W, Benedict CR, Hahne WF. A double-blind, placebo-controlled, doseranging safety evaluation of single-dose intravenous dolasetron in healthy male volunteers. J Clin Pharmacol 1995; 35: 705\u201312.","journal-title":"J Clin Pharmacol"},{"key":"BF03013339_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.1994.12.1.45","volume":"12","author":"MG Kris","year":"1994","unstructured":"Kris MG, Grunberg SM, Gralla RJ.et al. Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin. J Clin Oncol 1994; 12: 45\u20139.","journal-title":"J Clin Oncol"},{"key":"BF03013339_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2044.1994.tb03576.x","volume":"49","author":"GNC Kenny","year":"1994","unstructured":"Kenny GNC. Risk factors for postoperative nausea and vomiting. Anaesthesia 1994; 49(Suppl): 6\u201310.","journal-title":"Anaesthesia"},{"key":"BF03013339_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00000542-199301000-00004","volume":"78","author":"P Seuderi","year":"1993","unstructured":"Seuderi P, Wetchler B, Sung Y-F, et al. Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology 1993; 78: 15\u201320.","journal-title":"Anesthesiology"},{"key":"BF03013339_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2044.1994.tb03578.x","volume":"49","author":"M Rust","year":"1994","unstructured":"Rust M, Cohen LA. Single oral dose ondansetron in the prevention of postoperative nausea and emesis. Anaesthesia 1994; 49(Suppl): 16\u201323.","journal-title":"Anaesthesia"},{"key":"BF03013339_CR20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/oxfordjournals.annonc.a058049","volume":"2","author":"J Rusthoven","year":"1991","unstructured":"Rusthoven J, Pater J, Kaizer L, et al. A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy. Ann Oncol 1991; 2: 681\u20136.","journal-title":"Ann Oncol"},{"key":"BF03013339_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ddr.430240309","volume":"24","author":"PD Williams","year":"1991","unstructured":"Williams PD, Cohen ML, Turk JA. Electrocardiographic effects of zatosetron and ondansetron, two 5HT3 receptor antagonists, in anesthetized dogs. Drug Develop Res 1991; 24: 277\u201384.","journal-title":"Drug Develop Res"},{"key":"BF03013339_CR22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/BF03009516","volume":"40","author":"JS Heyman","year":"1993","unstructured":"Heyman JS, Young ML, Bagshaw RJ, et al. Cardiovascular stability with rapid intravenous infusion of ondansetron. Can J Anaesth 1993; 40: 448\u201352.","journal-title":"Can J Anaesth"},{"key":"BF03013339_CR23","first-page":"139","volume":"81","author":"PHDP Desilva","year":"1995","unstructured":"Desilva PHDP, Darvish AH, McDonald SM, Cronin MK, Clark K. The efficacy of prophylactic ondansetron, droperidol, perphenazine, and metoclopramide in the prevention of nausea and vomiting after major gynecologic surgery. Anesth Analg 1995; 81: 139\u201343.","journal-title":"Anesth Analg"},{"key":"BF03013339_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF03015482","volume":"42","author":"Y Fujii","year":"1995","unstructured":"Fujii Y, Tanaka H, Toyooka H. Granisetrondexamethasone combination reduces postoperative nausea and vomiting. Can J Anaesth 1995; 42: 387\u201390.","journal-title":"Can J Anaesth"},{"key":"BF03013339_CR25","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00000542-199511000-00007","volume":"83","author":"PJ Davis","year":"1995","unstructured":"Davis PJ, McGowan FX Jr, Landsman I, Maloney K, Hoffmann P. Effect of antiemetic therapy on recovery and hospital discharge time. Anesthesiology 1995; 83: 956\u201360.","journal-title":"Anesthesiology"}],"container-title":["Canadian Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03013339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03013339\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03013339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T18:55:04Z","timestamp":1558464904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03013339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["BF03013339"],"URL":"https:\/\/doi.org\/10.1007\/bf03013339","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}